Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker

BACKGROUND AND PURPOSE: The pathogenesis of moyamoya disease (MMD) remains poorly understood, and no reliable molecular biomarkers for MMD have been identified to date. The present study aimed to identify epigenetic biomarkers for use in the diagnosis of MMD. METHODS: We performed integrated analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Hye Youn, Lee, Ji Yeoun, Park, Ae Kyung, Moon, Youn Joo, Jo, Inho, Park, Eun-Mi, Wang, Kyu-Chang, Phi, Ji Hoon, Ahn, Jung-Hyuck, Kim, Seung-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186926/
https://www.ncbi.nlm.nih.gov/pubmed/30309230
http://dx.doi.org/10.5853/jos.2018.00962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186926/
https://www.ncbi.nlm.nih.gov/pubmed/30309230
http://dx.doi.org/10.5853/jos.2018.00962

Ejemplares similares